【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Incontinence Devices Overview 13
3 Products under Development 15
3.1 Incontinence Devices – Pipeline Products by Stage of Development 15
3.2 Incontinence Devices – Pipeline Products by Segment 16
3.3 Incontinence Devices – Pipeline Products by Territory 17
3.4 Incontinence Devices – Pipeline Products by Regulatory Path 18
3.5 Incontinence Devices – Pipeline Products by Estimated Approval Date 19
3.6 Incontinence Devices – Ongoing Clinical Trials 20
4 Incontinence Devices – Pipeline Products under Development by Companies 21
4.1 Incontinence Devices Companies – Pipeline Products by Stage of Development 21
4.2 Incontinence Devices – Pipeline Products by Stage of Development 24
5 Incontinence Devices Companies and Product Overview 27
5.1 American Medical Systems Holdings, Inc. Company Overview 27
5.1.1 American Medical Systems Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Applied Catheter Technologies Inc. Company Overview 34
5.2.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.3 AugmentRx Medical Inc. Company Overview 35
5.3.1 AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.4 Bioring SA (Inactive) Company Overview 36
5.4.1 Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 BioSurfaces, Inc. Company Overview 37
5.5.1 BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Boston Scientific Corporation Company Overview 38
5.6.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 44
5.7.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
5.8 Compactcath, Inc. Company Overview 45
5.8.1 Compactcath, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.9 Continara Limited (Inactive) Company Overview 46
5.9.1 Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 Continental Dry-Works Company Overview 47
5.10.1 Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 47
5.11 Covalon Technologies Ltd. Company Overview 48
5.11.1 Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
5.12 DUALIS MedTech GmbH Company Overview 50
5.12.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Elidah, LLC Company Overview 52
5.13.1 Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 EMKinetics, Inc. Company Overview 53
5.14.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.15 Endo International Plc Company Overview 54
5.15.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 54
5.16 EndoStim, Inc Company Overview 56
5.16.1 EndoStim, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Enox Biopharma, Inc Company Overview 57
5.17.1 Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Ethicon, Inc. Company Overview 58
5.18.1 Ethicon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 Facet Technologies, LLC Company Overview 60
5.19.1 Facet Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 60
5.20 FLEXIPROBE LTD. Company Overview 61
5.20.1 FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 61
5.21 Floelle Inc. Company Overview 62
5.21.1 Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Forconti Medical Ltd. Company Overview 63
5.22.1 Forconti Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 63
5.23 Future Path Medical Holding, LLC Company Overview 64
5.23.1 Future Path Medical Holding, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
5.24 Generic Medical Devices, Inc. Company Overview 65
5.24.1 Generic Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.25 GR Dome Medical Ltd. Company Overview 66
5.25.1 GR Dome Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.26 GT Urological, LLC Company Overview 67
5.26.1 GT Urological, LLC Pipeline Products & Ongoing Clinical Trials Overview 67
5.27 Jabil, Inc. Company Overview 73
5.27.1 Jabil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.28 Kleeven International BV Company Overview 74
5.28.1 Kleeven International BV Pipeline Products & Ongoing Clinical Trials Overview 74
5.29 Leto Medical, LLC Company Overview 75
5.29.1 Leto Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
5.30 Lilium Otsuka Co., Ltd. Company Overview 76
5.30.1 Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 76
5.31 Marvao Medical Devices Limited Company Overview 77
5.31.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.32 Medici Medical Srl Company Overview 78
5.32.1 Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 78
5.33 Medi-Globe GmbH Company Overview 79
5.33.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 79
5.34 Medisse BV Company Overview 80
5.34.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 80
5.35 Medtronic plc Company Overview 81
5.35.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 81
5.36 MyoPowers Medical Technologies SA Company Overview 83
5.36.1 MyoPowers Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 83
5.37 Nagasaki University Company Overview 85
5.37.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 85
5.38 NexHand Company Overview 86
5.38.1 NexHand Pipeline Products & Ongoing Clinical Trials Overview 86
5.39 Olympus Medical Systems Corp. Company Overview 87
5.39.1 Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 87
5.40 PercuVision LLC Company Overview 88
5.40.1 PercuVision LLC Pipeline Products & Ongoing Clinical Trials Overview 88
5.41 Precision Medical Devices, Inc. Company Overview 89
5.41.1 Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 89
5.42 Prosurg, Inc. Company Overview 91
5.42.1 Prosurg, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.43 Proxy Biomedical Limited Company Overview 93
5.43.1 Proxy Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 93
5.44 Quick-Med Technologies, Inc. Company Overview 94
5.44.1 Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.45 Salusion B.V. Company Overview 97
5.45.1 Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 97
5.46 Sharklet Technologies, Inc. Company Overview 98
5.46.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.47 Solace Therapeutics Company Overview 100
5.47.1 Solace Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 100
5.48 Teleflex Incorporated Company Overview 105
5.48.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 105
5.49 Tengion, Inc. Company Overview 108
5.49.1 Tengion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.50 The Feinstein Institute for Medical Research Company Overview 110
5.50.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 110
5.51 The University of Utah Company Overview 113
5.51.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 113
5.52 TheraNova, LLC. Company Overview 116
5.52.1 TheraNova, LLC. Pipeline Products & Ongoing Clinical Trials Overview 116
5.53 Universitat Politecnica de Catalunya Company Overview 117
5.53.1 Universitat Politecnica de Catalunya Pipeline Products & Ongoing Clinical Trials Overview 117
5.54 University of Basel Company Overview 119
5.54.1 University of Basel Pipeline Products & Ongoing Clinical Trials Overview 119
5.55 University of California, San Diego Company Overview 120
5.55.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 120
5.56 University of Michigan Pediatric Device Consortium Company Overview 121
5.56.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 121
5.57 University of Nottingham Company Overview 122
5.57.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 122
5.58 Urinary BioSolutions LLC Company Overview 123
5.58.1 Urinary BioSolutions LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.59 Uromedica, Inc. Company Overview 124
5.59.1 Uromedica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.60 Urova Medical Inc. Company Overview 130
5.60.1 Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 130
5.61 Urovalve, Inc. Company Overview 131
5.61.1 Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.62 Verathon Inc. Company Overview 134
5.62.1 Verathon Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.63 Vesiflo, Inc. Company Overview 137
5.63.1 Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.64 Victhom Human Bionics Inc. (Inactive) Company Overview 138
5.64.1 Victhom Human Bionics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 138
5.65 Vysera Biomedical Limited Company Overview 139
5.65.1 Vysera Biomedical Limited Pipeline Products & Ongoing Clinical Trials Overview 139
5.66 Xennovate Medical LLC Company Overview 140
5.66.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 140
6 Incontinence Devices- Recent Developments 142
7 Appendix 229
7.1 Methodology 229
7.2 About GlobalData 231
7.3 Contact Us 232
7.4 Disclaimer 232
【レポート販売概要】
■ タイトル：世界における失禁用デバイスの製品パイプライン動向2015■ 英文：Incontinence Devices - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0092EPD
■ 調査対象地域：グローバル
- NFV（ネットワーク機能の仮想化）市場：事例、市場分析、2014-2019予測）（The Network Functions Virtualization (NFV) Market: Business Case, Market Analysis & Forecasts 2014 – 2019）Network Functions Virtualization (NFV) is a telecom led initiative that aims to utilize standard IT virtualization technology to consolidate many telco network equipment types onto industry standard high volume servers, switches and storage. NFV involves implementing network functions in software that can run on a range of industry standard server hardware, and that can be moved to, or instantiate …
- BAX-855 (Hemophilia A and B)：市場予測と分析（～2022）BAX-855 (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
- 医用画像解析ソフトウェアの世界市場：タイプ別（スタンドアロン）、画像タイプ別（2D、3D、4D）、モダリティ別（CT、MRI、PET、超音波）、用途別（整形外科、歯科、腫瘍、腎臓疾患）、エンドユーザー別（病院、診断センター、研究）、地域別予測Global Medical image software analysis Market to reach USD 4.9 billion by 2025. Global Medical image software analysis Market valued approximately USD 2.41 billion in 2016 is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2017-2025. Key success factors for this market are; technological advancements in medical imaging systems & analysis software, growing …
- 圧縮天然ガス自動車（CNG車）の世界市場In 2015 the market for compressed natural gas vehicles is still in its infancy despite a growth in sales, especially through 2009 to 2014. The CNG Passenger Car market is currently characterised by a high level of concentration in a small number of countries, low penetration in the major automotive markets and limited supply of models by OEMs. The latter is mainly due to the significant upfront pu …
- スピルリナの世界市場：種類別（アルスロスピラプラテンシス、アルスロスピラマキシマ）、用途別（栄養補助食品、化粧品、食品および飲料、動物飼料、その他）、製剤別（粉末、錠剤・カプセル、液体、顆粒、ゲル化剤）Spirulina is a natural algae powder known as cyanobacteria that comprises potent level of proteins, antioxidants, and vitamin B and other nutrients. Spirulina exhibits various benefits such as lowering of LDL and triglyceride levels and anticancer properties. It also reduces blood pressure, is effective against anemia, and improves muscle strength. The global spirulina market generated $346 millio …
- 屋内ロケーションベースサービス（LBS）の世界市場：製品別、技術別（RFID・NFC、Wi-Fi/WLAN・BT/BLE）、用途別（トラッキング、近接、ナビゲーション）、最終用途別、セグメント予測The global indoor lbs market size is expected to reach USD 18.74 billion by 2025, according to a new study by Grand View Research, Inc., rising at a CAGR of 43.3% during the forecast period. Growing use of location-based services in the retail industry for marketing applications in expected to stimulate the growth of the market over the forecast period. Industry players are increasingly striving t …
- ジェスチャ認識技術および非接触感知製品の世界市場The gesture recognition & touchless sensingmarket is expected to grow at a rapid pace in most of the regions of the worlddue to a growing number of acquisitionsand the focus of playerstowards incorporating gesture recognition & touchless technology in their products. A high demand from the gaming sector coupled with rich graphics is a major factor driving the market growth. Further, initiatives fr …
- 中東/北アフリカのバイオメトリクス認証（生体認証）市場About biometrics Biometrics is based on the behavioural and physiological characteristics of an individual that are difficult to replicate. Biometric technologies include voice recognition, palm geometry recognition, DNA identification, gait recognition, fingerprint matching, facial recognition, iris recognition, signature verification, and vein recognition. Also, these technologies are considered …
- 病院用物流ロボットの世界市場2018-2022About Hospital Logistics Robots Hospital logistics robots comprise autonomous guided vehicles (AGVs) and mobile robot platforms. These are used for managing the flow of goods such as laboratory samples, food, pharmaceuticals, environmental waste, and laundry inside hospital premises. Technavio’s analysts forecast the global hospital logistics robots market to grow at a CAGR of 15.48% during the pe …
- 生体認証センサーの世界市場分析：製品別（容量性センサー、光学センサー、熱センサー、超音波センサー、電界センサー）、用途別（音声スキャン、指スキャン、手スキャン、顔面スキャン、虹彩スキャン、静脈スキャン）、エンドユーザー別（消費者家電、商業ビルディング、防衛、医療、BFSI）、セグメント予測The global Biometric Sensor Market size is expected to reach USD 1.83 billion by 2024, according to a new report by Grand View Research, Inc. Technological proliferation and increasing demand in commercial buildings, consumer electronics, and banking applications are expected to drive the market growth. The development of advanced multimodal techniques for biometric authentication and recognition …
- ハイブリッド電源装置の世界市場2019-2023Global Hybrid Power Systems Market: About this market Technavio’s hybrid power systems market analysis considers sales from solar-diesel, solar-wind-diesel, wind-diesel, and others. Our analysis also considers the sales of hybrid power systems in America, APAC, EMEA. In 2018, the solar-diesel segment had a significant market share, and this trend is expected to continue over the forecast period. F …
- オーストラリアのバイオ燃料産業分析：Analyzing the Biofuel Industry in AustraliaAlthough biofuels are mainly used to replace or supplement the traditional petroleum-based transportation fuels, they can also be deployed to generate heat and electricity. Being an alternative to fossils, biofuels can be applied to existing vehicles with little or no engine modification. Although they release CO2 when burned in internal combustion engines, they differ from fossil fuels partly bec …
- 石油・ガス産業向けドリルビットの世界市場2017-2021：フィックストカッタービット、ローラーコーンカッタービットAbout Drilling BitsDrill bits are mechanical tools used for cutting or crushing rocks to create wellbores for the extraction of hydrocarbon resources. They are mainly used in drilling operations for oil or gas wells either onshore or offshore. Technavio’s analysts forecast the global drilling bits market in oil and gas to grow at a CAGR of 4.75% during the period 2017-2021. [Covered in this report …
- 位置センサーの世界市場分析：技術別（光電、リニア、近接、ロータリー）、用途別（自動車、軍用･航空宇宙、電子･半導体、包装）、セグメント予測The global position sensors market is expected to reach USD 9.93 billion by 2022, according to a new report by Grand View Research, Inc. Increasing demand for electronics and sensor systems in automobiles is expected to augment demand. Factors such as the need for contactless technologies, requirement for lower CO2 emissions, and improvement in reliability and precision are expected to trigger dem …
- Cross Border Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Cross Border Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Cross Border Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
